|
15-Lipoxygenase-2 (ALOX15B) as a Tumor Suppressor
|
5R01CA131445-05
|
$214,879
|
$53,720
|
NIE, DAOTAI
|
SOUTHERN ILLINOIS UNIVERSITY SCH OF MED
|
|
2012 Cell Death Gordon Research Conference
|
2R13CA153310-02
|
$8,000
|
$2,000
|
ABRAMS, JOHN
|
GORDON RESEARCH CONFERENCES
|
|
A Cellular and Molecular Analysis of the Intravasation Step in Tumor Metastasis
|
5R01CA129484-05
|
$381,417
|
$23,839
|
QUIGLEY, JAMES
|
SCRIPPS RESEARCH INSTITUTE
|
|
A Follow-up Study for Causes of Illness in Black Women
|
5R01CA058420-19
|
$1,716,455
|
$858,228
|
Rosenberg, Lynn
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
A Genetic Model for Early-Onset Breast and Colon Cancer in African Americans
|
1U01CA158428-01A1
|
$342,475
|
$85,619
|
Buckhaults, Phillip
|
GEORGIA HEALTH SCIENCES UNIVERSITY
|
|
A Longitudinal Study of the Predictors of Smoking in Women in Late Midlife
|
5R01CA122128-05
|
$512,023
|
$512,023
|
BROOK, JUDITH
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
A Multi-State Study of Cancer Treatment and Outcomes Among American Indians
|
5R01CA125231-06
|
$374,097
|
$28,057
|
RAMSEY, SCOTT
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
A MULTILEVEL APPROACH TO ENERGY BALANCE AND CANCER ACROSS THE LIFECOURSE
|
5U54CA155496-02
|
$1,712,824
|
$137,026
|
COLDITZ, GRAHAM
|
WASHINGTON UNIVERSITY
|
|
A novel function of TIMP-1
|
5R01CA089113-10
|
$261,358
|
$26,136
|
KIM, HYEONG-REH
|
WAYNE STATE UNIVERSITY
|
|
A Novel Mechanism for Control of Androgen Receptor Levels in HRPC
|
5R01CA138583-02
|
$280,125
|
$70,031
|
HAMBURGER, ANNE
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
A Novel Synthetic Androgen Receptor Antagonist
|
5R01CA131137-05
|
$313,989
|
$78,497
|
DONG, ZHONGYUN
|
UNIVERSITY OF CINCINNATI
|
|
A Platform for Cancer Biomarker Validation: Image Fusion Using NIR Fluorescence
|
5R01CA134493-04
|
$688,070
|
$172,018
|
Frangioni, John
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
A Systems Genetics Analysis of Cancer Risk, Progression and Therapeutic Response
|
5U01CA084244-14
|
$759,738
|
$151,948
|
BALMAIN, ALLAN
|
UNIVERSITY OF CALIFORNIA-SAN FRANCISCO
|
|
AARP prospective study of diet and cancer
|
ZIA CP010196-03152
|
$1,258,475
|
$629,238
|
Sinha, Rashmi
|
DCEG (NCI)
|
|
Abramson Cancer Center Support Grant
|
5P30CA016520-36
|
$7,725,062
|
$77,251
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
ACOSOG Community Clinical Oncology Program (CCOP) Research Base
|
5U10CA149950-02
|
$1,474,780
|
$44,243
|
Sloan, Jeff
|
MAYO CLINIC
|
|
Adiposity and Outcomes of Clinically Localized Prostate Cancer
|
5R01CA129140-04
|
$569,690
|
$142,423
|
Freeman, Vincent
|
UNIVERSITY OF ILLINOIS
|
|
Adult Leukemia Research Center
|
2P01CA018029-37A1
|
$4,225,448
|
$591,563
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Advanced glycation end products and colorectal cancer risk in women
|
5R03CA156626-02
|
$80,193
|
$40,097
|
JIAO, LI
|
BAYLOR COLLEGE OF MEDICINE
|
|
Adverse Drug Reactions in Geriatric Cancer Patients
|
5K01CA134554-05
|
$126,762
|
$126,762
|
MCKOY, JUNE
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
Aging and Primary Central Nervous System Tumors
|
ZIABC011348
|
$62,975
|
$47,232
|
Iwamoto, Fabio
|
CCR (NCI)
|
|
Aging and Prostate Cancer Risk--the Role of T Cell Dysfunction
|
5R03CA156404-02
|
$77,000
|
$77,000
|
DE GRAFFENRIED, LINDA
|
UNIVERSITY OF TEXAS AUSTIN
|
|
Aldo-Keto Reductases and PAH Metabolism/Activation
|
5R01CA039504-26
|
$280,504
|
$14,025
|
Penning, Trevor
|
UNIVERSITY OF PENNSYLVANIA
|
|
Alternative splicing and epithelial-mesenchymal plasticity in prostate tumors
|
5R01CA127727-04
|
$313,989
|
$78,497
|
Garcia-Blanco, Mariano
|
DUKE UNIVERSITY
|
|
An androgen receptor coactivator regulated in prostate
|
5R01CA112226-05
|
$341,161
|
$85,290
|
LOGAN, SUSAN
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Androgen Receptor Function in Prostate Cancer
|
3R01CA086072-10S1
|
$77,500
|
$19,375
|
PESTELL, RICHARD
|
THOMAS JEFFERSON UNIVERSITY
|
|
Androgen Receptor Function in Prostate Cancer
|
5R01CA086072-10
|
$310,970
|
$77,743
|
PESTELL, RICHARD
|
THOMAS JEFFERSON UNIVERSITY
|
|
Anti-topoisomerase drug action in yeast
|
5R01CA052814-19
|
$282,872
|
$14,144
|
NITISS, JOHN
|
UNIVERSITY OF ILLINOIS
|
|
Anticancer Strategies Targeting the Autotaxin-LPA Receptor Axis
|
2R01CA092160-11
|
$302,203
|
$30,220
|
TIGYI, GABOR
|
UNIVERSITY OF TENNESSEE HEALTH SCI CTR
|
|
Arizona Cancer Center-Cancer Center Support Grant
|
3P30CA023074-34S1
|
$75,000
|
$2,250
|
Alberts, David
|
UNIVERSITY OF ARIZONA
|
|
Arizona Cancer Center-Cancer Center Support Grant
|
3P30CA023074-34S2
|
$143,846
|
$4,315
|
Alberts, David
|
UNIVERSITY OF ARIZONA
|
|
Arizona Cancer Center-Cancer Center Support Grant
|
5P30CA023074-34
|
$3,953,813
|
$118,614
|
Alberts, David
|
UNIVERSITY OF ARIZONA
|
|
Arsenic Trioxide and Acute Myeloid Leukemia
|
5R01CA093533-09
|
$247,445
|
$123,723
|
JING, YONGKUI
|
MOUNT SINAI SCHOOL OF MEDICINE
|
|
ATBC Study
|
ZIA CP010195-03031
|
$1,176,890
|
$58,845
|
Albanes, Demetrius
|
DCEG (NCI)
|
|
Atlanta Regional Community Clinical Oncology Program (ARCCOP)
|
5U10CA045450-26
|
$562,599
|
$16,878
|
SEAY, THOMAS
|
ST. JOSEPH'S HOSPITAL
|
|
Atlases to Report and Correlate Radiotherapy Dose Distributions with Outcomes
|
5R01CA129182-04
|
$435,472
|
$54,434
|
Jackson, Andrew
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
Autoimmunity and anti tumor immunity outside of the melanocyte/melanoma paradigm
|
5R01CA132734-05
|
$304,127
|
$38,016
|
Vile, Richard
|
MAYO CLINIC
|
|
B-cell repertoires in chronic lymphocytic leukemia
|
5R01CA081554-09
|
$311,150
|
$311,150
|
Chiorazzi, Nicholas
|
FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH
|
|
Bay Area Tumor Institute CCOP
|
2U10CA045461-23
|
$486,165
|
$19,447
|
FEUSNER, JAMES
|
BAY AREA TUMOR INSTITUTE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-06S1
|
$41,433
|
$1,243
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-06S2
|
$75,000
|
$2,250
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-06
|
$2,934,758
|
$88,043
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Bcl-2 function on the endoplasmic reticulum
|
5R01CA085804-13
|
$284,448
|
$14,222
|
DISTELHORST, CLARK
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Beaumont Community Clinical Oncology Program
|
3U10CA095860-11S1
|
$140,000
|
$4,200
|
Robertson, John
|
WILLIAM BEAUMONT HOSPITAL RESEARCH INST
|
|
Beaumont Community Clinical Oncology Program
|
5U10CA095860-11
|
$771,835
|
$23,155
|
Robertson, John
|
WILLIAM BEAUMONT HOSPITAL RESEARCH INST
|
|
Bioavailability and activity of dietary naringenin as a chemopreventive agent
|
1R03CA162551-01A1
|
$75,631
|
$75,631
|
BELURY, MARTHA
|
OHIO STATE UNIVERSITY
|
|
Biobehavioral Cancer Prevention and Control Training Program
|
3R25CA092408-12S1
|
$45,391
|
$11,348
|
Patrick, Donald
|
UNIVERSITY OF WASHINGTON
|
|
Biobehavioral Cancer Prevention and Control Training Program
|
5R25CA092408-12
|
$421,086
|
$105,272
|
Patrick, Donald
|
UNIVERSITY OF WASHINGTON
|
|
Breast and Other Cancers in the California Teachers Cohort
|
5R01CA077398-14
|
$2,522,927
|
$756,878
|
BERNSTEIN, LESLIE
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Breast Carcinoma in situ: Predicting Risk and Outcomes
|
5R01CA067264-13
|
$339,702
|
$33,970
|
TRENTHAM-DIETZ, AMY
|
UNIVERSITY OF WISCONSIN-MADISON
|
Total relevant funding to Aging for this search: $86,910,095
|